Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trialBradley J. Monk, Jyoti Mayadev, R. Tarnawski et al.|The Lancet Oncology|2023Cited by 214
O001/#504 Durvalumab, in combination with and following chemoradiotherapy, in locally advanced cervical cancer: results from the phase 3 international, randomized, double-blind, placebo-controlled calla trialBradley J. Monk, Jyoti Mayadev, Takafumi Toita et al.|International Journal of Gynecological Cancer|2022Cited by 15